Liang Ruilong, Tang Lin, Li Lutong, Zhao Na, Yu Xintong, Li Jinjin, Wang Qianqian, Cun Haifeng, Gao Xiaolin, Yang Wenjia
Department of Acupuncture and Moxibustion, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Neurol. 2024 Dec 18;15:1481557. doi: 10.3389/fneur.2024.1481557. eCollection 2024.
To evaluate the effect of pressing needle therapy on depression, anxiety, and sleep in patients recovering from COVID-19, and to provide a more effective and convenient treatment for the sequelae of COVID-19.
A total of 136 patients recovering from COVID-19 were randomized into a treatment group (68 cases) and a control group (68 cases, with one case dropping out). The treatment group received pressing needle therapy, while the control group received sham pressing needle therapy, three times a week for 4 weeks. The Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and Insomnia Severity Index (ISI) were used to evaluate patients' emotional states and sleep quality. These scales were assessed before, after, and at a 1-month follow-up.
Compared to before treatment, the treatment group showed a significant decrease in PHQ-9 scores ( < 0.05, Cohen's d = 1.26), GAD-7 scores ( < 0.05, Cohen's d = 1.10), and ISI scores ( < 0.05, Cohen's d = 0.94) after treatment. Similarly, at the 1-month follow-up, significant decreases were observed in PHQ-9 scores ( < 0.05, Cohen's d = 1.11), GAD-7 scores ( < 0.05, Cohen's d = 0.88), and ISI scores ( < 0.05, Cohen's d = 0.94). In contrast, the control group demonstrated no statistically significant differences in PHQ-9, GAD-7, or ISI scores after treatment or at the 1-month follow-up ( > 0.05). Between the two groups, statistically significant improvements ( < 0.05) were observed in PHQ-9 scores (Cohen's d = 1.47), GAD-7 scores (Cohen's d = 1.61), and ISI scores (Cohen's d = 1.06) after treatment. At the 1-month follow-up, statistically significant differences ( < 0.05) between the two groups were also noted in PHQ-9 scores (Cohen's d = 1.10), GAD-7 scores (Cohen's d = 0.87), and ISI scores (Cohen's d = 0.92).
Pressing needle therapy significantly improves the mental health and sleep quality of patients recovering from COVID-19. It enhances their quality of life, promotes early recovery, and is simple and easy to administer, making it a treatment worthy of clinical application.
评估揿针疗法对新型冠状病毒肺炎（COVID-19）康复期患者抑郁、焦虑及睡眠的影响，为COVID-19后遗症提供更有效、便捷的治疗方法。
将136例COVID-19康复期患者随机分为治疗组（68例）和对照组（68例，1例失访）。治疗组接受揿针疗法，对照组接受假揿针疗法，每周3次，共4周。采用患者健康问卷（PHQ-9）、广泛性焦虑障碍量表（GAD-7）和失眠严重程度指数（ISI）评估患者的情绪状态和睡眠质量。这些量表在治疗前、治疗后及1个月随访时进行评估。
与治疗前相比，治疗组治疗后PHQ-9评分（<0.05，Cohen's d = 1.26）、GAD-7评分（<0.05，Cohen's d = 1.10）和ISI评分（<0.05，Cohen's d = 0.94）显著降低。同样，在1个月随访时，PHQ-9评分（<0.05，Cohen's d = 1.11）、GAD-7评分（<0.05，Cohen's d = 0.88）和ISI评分（<0.05，Cohen's d = 0.94）也显著降低。相比之下，对照组治疗后及1个月随访时PHQ-9、GAD-7或ISI评分无统计学显著差异（>0.05）。两组之间，治疗后PHQ-9评分（Cohen's d = 1.47）、GAD-7评分（Cohen's d = 1.61）和ISI评分（Cohen's d = 1.06）有统计学显著改善（<0.05）。在1个月随访时，两组之间在PHQ-9评分（Cohen's d = 1.10）、GAD-7评分（Cohen's d = 0.87）和ISI评分（Cohen's d = 0.92）方面也有统计学显著差异（<0.05）。
揿针疗法显著改善了COVID-19康复期患者的心理健康和睡眠质量。提高了他们的生活质量，促进了早期康复，且操作简单，是一种值得临床应用的治疗方法。
